Clinical trial
A Trial in Healthy Volunteers, to Evaluate the Tolerability and Cardiac Safety…
NCT00488215 · Movetis, Industry · Completed
Key facts
| NCT number | NCT00488215 |
|---|---|
| Title | A Trial in Healthy Volunteers, to Evaluate the Tolerability and Cardiac Safety of Prucalopride |
| Official title | A Double-Blind, Placebo-Controlled, 2-Way Cross-Over Trial in Healthy Volunteers, to Evaluate the Pharmacokinetics, Tolerability and Cardiac Safety of Oral Prucalopride at Steady State, After up-Titration to a Maximum of 20 mg. |
| Lead sponsor | Movetis, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Constipation |
| Intervention type | Drug, Other |
| Interventions | prucalopride, Placebo |
| Enrollment | 32 |
| Start date | Jan 1, 2000 |
| Primary completion | Mar 1, 2000 |
| Completion | Mar 1, 2000 |
| First posted | Jun 20, 2007 |
| Last update posted | May 29, 2008 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: